Smoker who was diagnosed with prostate cancer will face a more malignant tumor and the risk of dying from the disease than men non-smokers.
The conclusion of research by a team from the Harvard School of Public Health and the University of California found that the risk of death from prostate cancer in male smokers to 61 percent. Likewise, the risk for disease recurrence after therapy.
Between smokers and nonsmokers whose cancer has not spread when diagnosed, or in medical language is called non-metastatic cancer, the risk of death faced by smokers to 80 percent.
However, smokers who had quit for 10 years or older when diagnosed with prostate cancer have the same opportunities as men nonsmokers, both in recurrence and mortality risk.
"The data this research because only a little relief that we know to reduce the risk of death from prostate cancer. It can also be a reason not to smoke," says Edward Giovannucci, professor of nutrition and epidemiology at Harvard.
The study examined health data from 5366 men diagnosed with prostate cancer between 1986 and 2006. In that period, 1630 died, 524 (32 percent) due to prostate cancer and 416 (26 percent) due to heart disease.
Prostate cancer is a type of cancer the most common cancer in American men and about 1 of 6 men in his life. You have read Prostate Cancer and Smoking, Deadly Combination
